Mitochondria-Targeting 1H-Imidazo[4,5- f ][1,10]phenanthroline-Based Binuclear Ru(II)/Ir(III)/Re(I) Complexes as a Promising Avenue for In Vitro Genotoxicity and In Vivo Tumor Immunotherapy
Journal of Medicinal Chemistry · 09.10.2025 · 68 (19) · 20011-20036
DOI: 10.1021/acs.jmedchem.5c00523 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, online erschienen am 25.09.2025. Verfasst von Binoy Kar und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, School of Advanced Sciences, Vellore Institute of Technology, Vellore, Tamilnadu 632014, India. Hauptthemen laut MEDLINE: Mitochondria, Coordination Complexes, Antineoplastic Agents, Phenanthrolines. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 51 Literaturangaben. Gefördert von: Council of Scientific and Industrial Research, India, Science and Engineering Research Board, Ministry of Minority Affairs.
Abstract (Originalsprache)
Bimetallic complexes have recently emerged as a promising tool for synergistic photodynamic therapy and chemotherapy in oncology. However, the effectiveness of existing therapies remains limited in the treatment of triple-negative breast cancer (MDA-MB-231) and human melanoma cancer (A375). In this study, we introduced mitochondrial-targeting imidazophenanthroline-based binuclear Ru(II)/Ir(III)/Re(I) complexes capable of generating ROS, facilitating mitochondrial dysfunction and oxidative DNA damage, and inducing G0/G1 phase cell cycle arrest. Among all these complexes, the naphthalene-substituted imidazophenanthroline-based bisiridium complex (BNS-2) exhibited the best potency against MDA-MB-231 TNBC and A375 cancer cell lines. Eventually, this complex induced the upregulation of BAX and cleaved caspase-3, downregulated BCL-2, triggered the caspase 3/9 pathway for apoptosis, and shifted the death mechanism from necrosis to apoptosis in tumor cells in vivo. This complex significantly reduced tumor volume and protected the mice against significant weight loss without causing liver or kidney toxicity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Chemistry, School of Advanced Sciences, Vellore Institute of Technology, Vellore, Tamilnadu 632014, India.
- Department of Zoology, West Bengal State University, Berunanpukuria, Malikapur, Barasat, North 24 Parganas, Kolkata, West Bengal 700126, India.
- Department of Chemistry, National Institute of Technology Agartala, Jirania, West Tripura Pin-799046, India.
- Department of Chemistry, Alipurduar University, Alipurduar, West Bengal 736122, India.
ORCID-Profile: Binoy Kar, Ashikur Rahaman, Priyankar Paira
Förderung
- Council of Scientific and Industrial Research, India
- Science and Engineering Research Board
- Ministry of Minority Affairs
Zitieren
APA
Kar, B., Rahaman, A., Pal, M., Banerjee, A., Roy, M., Chakrabarty, R., Bhattacharjee, S., Mandal, D. P., & Paira, P. (2025). Mitochondria-Targeting 1H-Imidazo[4,5- f ][1,10]phenanthroline-Based Binuclear Ru(II)/Ir(III)/Re(I) Complexes as a Promising Avenue for In Vitro Genotoxicity and In Vivo Tumor Immunotherapy. Journal of Medicinal Chemistry, 68(19), 20011-20036. https://doi.org/10.1021/acs.jmedchem.5c00523
Vancouver
Kar B, Rahaman A, Pal M, Banerjee A, Roy M, Chakrabarty R, et al. Mitochondria-Targeting 1H-Imidazo[4,5- f ][1,10]phenanthroline-Based Binuclear Ru(II)/Ir(III)/Re(I) Complexes as a Promising Avenue for In Vitro Genotoxicity and In Vivo Tumor Immunotherapy. Journal of Medicinal Chemistry. 2025;68(19):20011-20036. doi:10.1021/acs.jmedchem.5c00523
BibTeX
@article{Kar2025,
author = {Kar, Binoy and Rahaman, Ashikur and Pal, Maynak and Banerjee, Ankur and Roy, Mithun and Chakrabarty, Rinku and Bhattacharjee, Shamee and Mandal, Deba Prasad and Paira, Priyankar},
title = {Mitochondria-Targeting 1H-Imidazo[4,5- f ][1,10]phenanthroline-Based Binuclear Ru(II)/Ir(III)/Re(I) Complexes as a Promising Avenue for In Vitro Genotoxicity and In Vivo Tumor Immunotherapy},
journal = {Journal of Medicinal Chemistry},
year = {2025},
volume = {68},
number = {19},
pages = {20011--20036},
doi = {10.1021/acs.jmedchem.5c00523}
}
EUVIMED